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Personal lubricant use is common during anal intercourse. Some water-based products
with high osmolality and low pH can damage genital and rectal tissues, and the polymer
polyquaternium 15 (PQ15) can enhance HIV replication in vitro. This has raised concerns
that lubricants with such properties may increase STD/HIV infection risk, although in vivo
evidence is scarce. We use a macaque model to evaluate rectal cytotoxicity and SHIV infec-
tion risk after use of a highly osmolar (>8,000 mOsm/kg) water-based lubricant with pH of
4.4, and containing PQ15.
Methods
Cytotoxicity was documented by measuring inflammatory cytokines and epithelial tissue
sloughing during six weeks of repeated, non-traumatic lubricant or control buffer applica-
tions to rectum and anus. We measured susceptibility to SHIVSF162P3 infection by compar-
ing virus doses needed for rectal infection in twenty-one macaques treated with lubricant or
control buffer 30 minutes prior to virus exposure.
Results
Lubricant increased pro-inflammatory cytokines and tissue sloughing while control buffer
(phosphate buffered saline; PBS) did not. However, the estimated AID50 (50% animal infec-
tious dose) was not different in lubricant- and control buffer-treated macaques (p = 0.4467;
logistic regression models).
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Conclusions
Although the test lubricant caused acute cytotoxicity in rectal tissues, it did not increase sus-
ceptibility to infection in this macaque model. Thus neither the lubricant-induced type/extent
of inflammation nor the presence of PQ15 affected infection risk. This study constitutes a
first step in the in vivo evaluation of lubricants with regards to HIV transmission.
Introduction
Lubricant use is common in men and in women who practice anal intercourse [1–7]. Personal
lubricants are commercially available products marketed to enhance sexual pleasure and to re-
duce mechanical friction and tissue injury during sex. There is a wide variety of products on
the market [8] in diverse gel or liquid formulations, and also co-packaged with condoms. Their
chemical composition varies, and can be aqueous-, oil-, or silicone-based. Lubricant ingredi-
ents are typically from the “GRAS” list (generally recognized as safe), and do not contain
pharmacologically active ingredients.
Recent scientific studies raise concerns about the safety of some personal lubricants [9–13]
and their potentially damaging impact on genital epithelial tissues. The rectum may be particu-
larly vulnerable to such damage because it is lined by a single cell layer of columnar epithelial
cells, while vaginal or penile tissues have several layers of stratified epithelium. This is relevant
for sexually transmitted infections (STI) acquisition, including HIV, since epithelial tissues are
barriers for sexually transmitted pathogens.
An emerging hypothesis is that the hyper-osmolality of many water-based lubricants corre-
lates with epithelial tissue damage they induce [9–13]. When epithelial cells are subjected to a
hyper-osmolar environment, they release water, leading to cell shrinkage and damage. This can
cause breaks in epithelial integrity, and could thereby facilitate entry of invading pathogens, in-
cluding HIV, to underlying tissues where susceptible HIV target cells reside. Hyper-osmolality
is caused by high concentrations of salts in lubricants, even if the chemicals are considered safe
in lower concentrations. Results from several studies support an association of lubricant osmo-
lality with cytotoxicity: Aqueous hyper-osmolar lubricants have cytotoxic effects on epithelial
cells in in vitromodels [10,14], in ex vivo tissue explants models [9], and in slug mucosal irrita-
tion assays [13]. Importantly, the one observational study in humans of a hyper-osmolar mix-
ture of lubricants demonstrated epithelial damage in the human colon [12]. In vivo studies of
rectal hyper-osmolar lubricant use in mice also documented rectal tissue sloughing, a sign of
epithelial tissue damage [11]. In addition to hyper-osmolality, lubricants may have other prop-
erties that may affect the genital environment and susceptibility to infection [15]. Polymers like
PQ15 added to stabilize aqueous solutions and gels may enhance viral replication, and could
thereby enhance sexual virus transmission, including HIV [10]. Thus, there are several poten-
tial mechanisms of lubricant-induced tissue damage, but cytotoxicity due to hyper-osmolality
has emerged as a leading concern. Despite these data, to date, only one observational study has
examined the impact of lubricant use on STI prevalence, and found that rectal lubricant use
was associated with increased prevalence of STIs including rectal gonorrhea, chlamydia, and
syphilis [16]. Nonetheless, the WHO issued an interim advisory note in 2012 to procurement
agencies to avoid purchasing lubricants with osmolality>1,200 mOsm/kg, with pH< 5.5, and
containing polymer, PQ15 [17].
Macaques are uniquely suited for studies on HIV risk and prevention because they can be
mucosally infected with the HIV homologues, SIV and SHIV. We report the development of a
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cynomolgus macaque model for evaluation of rectal lubricants, focusing on defining induction,
extent, and duration of cytotoxic effects. In this model, HIV acquisition risk was assessed thirty
minutes after rectal lubricant use, when cytokine expression was greatest. We selected a water-
based lubricant with high hyperosmolality (8,064 mOsm/kg), pH of 4.4, and containing PQ15
[10]. The product was selected before the WHO advisory note was issued; our test lubricant
had several properties cautioned against by the WHO, and was well above the natural osmolali-




The study lubricant was bought in two batches from a local supermarket, and stored at room
temperature as the label recommended. The product is not named in this publication to avoid
targeting a product of a single manufacturer. It had the following chemical properties: osmolal-
ity: 8,064 mOsm/kg, pH: 4.44 as reported by Begay et al. [10]; ingredients named on package
without quantitation: glycerin, propylene glycol, polyquaternium 15, methylparaben,
and propylparaben.
Ethics statement
Macaque experiments were performed according to NIH guidelines [18] and approved by the
Institutional Animal Care and Use Committee (IACUC) of the Centers for Disease Control
and Prevention (CDC; protocol 2249 KERMONC). Twenty one adult female cynomolgus ma-
caques were purchased from a US vendor (SNBL USA, Ltd; Everett, WA), and housed at CDC.
Infection data of an additional eleven cynomolgus macaques using 50 or 250 TCID50
SHIV162p3 from various unpublished studies were included as historical controls. All animal
procedures were performed under anesthesia (10 mg/kg ketamine or 4mg/kg telazol; intramus-
cular). For housing, macaques were maintained in cages that met (or exceeded) the minimum
size requirements as stipulated in the Guide for the Care and Use of Laboratory Animals, 8th
Ed. [cage dimensions (inches): 30 (height) x 30 (width) x 30 (length)]. Steps were taken to re-
duce animal suffering, which included providing enrichment opportunities [e.g. cage features
like swings/perches and objects for the macaques to manipulate], an assortment of food selec-
tions like fruits, vegetables or seeds, suitable feeding methods (foraging and task-oriented), and
humane interactions with caregivers and research staff. Prior to the initiation of virus inocula-
tions, compatible macaques were pair-housed. Once these inoculations were initiated, the ma-
caques were separated into single housing (while permitting eye-contact) with a cage divider to
prevent the possibility of SHIV transmission between the macaques. If one macaque remained
uninfected during the course of the study, the animal remained separated from other infected
macaques, and was not be pair-housed with an infected macaque during the follow-up period.
Euthanasia of SHIV infected macaques were accomplished in a humane manner (intravenous
pentobarbital) by acceptable techniques as recommended by the American Veterinary Medical
Association Guidelines on Euthanasia, 2013, and in accordance with CDC-Atlanta IACUC
Policy on Euthanasia. The attending veterinarian and/or trained Animal Resources Branch
(ARB) staff verified successful euthanasia by the lack of a heart beat and respiration.
Time course and sample collection
For cytotoxicity studies, macaques received non-traumatic applications of lubricant (n = 6) or
phosphate buffered saline (PBS; n = 3) twice a week in a study design shown in Fig. 1, A. PBS
Rectal Lubricants and Risk of SHIV Infection
PLOS ONE | DOI:10.1371/journal.pone.0120021 April 8, 2015 3 / 17
was chosen because the test lubricant was a liquid, not a gel. Using a 10cc syringe attached to a
flexible sterile 8-gauge feeding tube, 3mls of lubricant or PBS were gently infused into the rec-
tum 2–4cm beyond the anal sphincter. This was followed by gentle application of another 2mls
to the anal area with a swab. Samples were acquired at baseline for three weeks, and then as
shown in Fig. 1, A. Rectal pH was determined by rolling a polyester swab against the rectal
wall, approximately 3cm beyond the anal sphincter, and dabbing it onto a pH indicator strip.
For cytokine measurements, Merocel sponges (Medtronic, Jacksonville, FL) pre-wet with ster-
ile PBS were placed for 2 minutes in the rectum approximately 3cm beyond the anal sphincter,
Fig 1. Cytotoxicity study design (Phase I) and induction of pro-inflammatory cytokines. Study design
showing the cytotoxicity phase of the study (A); black rectangles = lubricant application; grey
triangles = sample collections immediately prior to each product application (longitudinal time points); black
triangles = samples taken 15 minutes to 48 hours after product application (acute time points); open
hexagons = rectal biopsies, taken from one animal at 30 minutes post lubricant-application, and from one
animal a week after last lubricant application; m = minutes; h = hours; B. Induction of pro-inflammatory
cytokine TNF-α at acute time points (15 or 30 m, and 2, 4, 24, or 48 h post-product application); circles
represent individual macaques; C. Induction of pro-inflammatory cytokine TNF-α at all time points during
6 weeks of product application; medians and ranges are graphed.
doi:10.1371/journal.pone.0120021.g001
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and allowed to absorb rectal secretions. Post-collection, samples were kept on ice and processed
immediately using a mild extraction buffer with the following protease inhibitors: trypsin-chy-
motrypsin inhibitor (5μg/mL), E-64 (14μM) and bestatin (130μM) (Sigma, St. Louis, MO).
Rectal lavage was obtained by injecting 8ml of PBS into the rectum of the macaques positioned
at a 30° angle to reduce trauma during collection [19]. PBS was gently recovered after 20–
30 seconds.
Epithelial tissue sloughing assay, associated blood
Rectal lavages were immediately assessed for epithelial sloughing (epithelial sheets3mm in
any dimension) [18], and associated blood using a dissecting microscope. To reduce fecal back-
ground, lavages were PBS-diluted and transferred to clean plates. High resolution images were
obtained using an Axiophot upright microscope (Carl Zeiss, Oberkochen, Germany). Samples
were also examined by hematoxylin and eosin (H&E) staining.
Microflora
Rectal swabs were collected, placed in Port-a-Cul tubes (BD, Franklin Lakes, NJ), and the mi-
croflora analyzed (for types and total numbers of cultivable bacteria) at Magee-Womens Re-
search Institute (Pittsburgh, PA).
Histopathological Evaluation and Immunohistochemical (IHC) Assays
Pinch biopsies from 3–5cm beyond the anal sphincter were fixed in formaldehyde, and stored
at room temperature in 70% ethanol. H&E stains of the rectal biopsies were evaluated for histo-
pathological changes as previously described [19]. IHC assays were performed on 3μm tissue
sections using antibodies against CD68, CD3 (DAKO, Carinteria, CA), or CD79 (Santa Cruz
Biotechnology, Inc). Negative controls consisted of sequential tissue sections incubated with ei-
ther normal rabbit (CD3) or mouse serum (CD79, CD68).
Cytokine measurements
Rectal secretions eluted from Merocel sponges were assessed for cytokines, chemokines, and
other inflammatory markers (IL-1β, IL-1Ra, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IL-13, IL-
15, IL-17, IL-18, G-CSF, GM-CSF, IFN-γ, TNF-a, MIP1α, MIP1β, MCP1, TGFA, VEGF,
sCD40) using Luminex bead technology (Bioplex, Biorad, Hercules, CA) and a non-human
primate cytokine bead panel (Millipore, Billerica, MA). The measured proteins were normal-
ized against total soluble protein levels in the rectal secretions determined using Quick Start
Bradford protein assay (Biorad, Hercules, CA).
Virus challenges and virus detection
To determine susceptibility to infection, we compared virus doses needed for infection in 21 lu-
bricant- or control buffer-treated cynomolgus macaques using an animal model modified from
earlier reports [20,21]. Thirty minutes after lubricant application, animals were exposed rectal-
ly to virus at varying doses (1.25–25,000 tissue culture infectious doses [TCID50]) of
SHIVSF162P3 obtained from NIH [22], propagated in cynomolgus macaque PBMCs. First, we
challenged the PBS-treated animals in sets of ten and nine macaques each. The uninfected ma-
caques (n = 12; rested for at least 6 weeks) and two additional macaques were then lubricant-
treated and exposed to various virus doses. Plasma viral RNA was measured by reverse-tran-
scriptase polymerase chain reaction (PCR) with a 50 copies/ml detection limit [23]. In addition
to viral RNA detection on two consecutive blood draws, in-house SHIV proviral real-time PCR
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assays and EIA detection of HIV envelope-specific antibodies (Bio-Rad HIV-1/HIV-2 Plus O
EIA, Hercules, CA) confirmed infections. For viral RNA determination in the rectal lavages,
samples were quick spun at low speeds to remove fecal debris, and supernatants stored at
−80°C until viral RNA determination.
Statistical evaluation
For cytokine analyses, we converted all cytokine measurements below the limit of detection
(LOD) to the actual LOD value given for that particular cytokine in the manufacturer’s kit
manual. For each study arm, we compared the geometric mean (GM) of baseline measure-
ments to those at acute time points (15m, 30m, 2h, 4h) post-PBS or lubricant application. To
ascertain differences between the two arms, we calculated the ratio of the GM ratios in the two
arms normalized to baseline. Statistical differences were estimated using 2-tailed unpaired t-
tests. To compare sloughing and rectal pH, with and without lubricant application, a 2-sided
Fisher’s exact probability test and a 2-tailed Mann-Whitney test were used, respectively. Statis-
tical comparisons could not be made for bleeding because of the limited data set. We calculated
animal infectious doses (AID50) by modeling HIV infection as a function of the log10 TCID50.
The log10 AID50 values were estimated from the logistic regression model for the lubricant and
control groups, and compared using an unpaired t-test.
Results
Cytotoxicity evaluation
Fig. 1, A shows the study design and sample collection schedule for assessing longitudinal or
acute cytotoxic lubricant effects over six treatment weeks with twice weekly product applica-
tions on consecutive days in nine macaques (n = 6 lubricant-treated, n = 3 PBS-treated con-
trols). “Longitudinal samples” refer to those collected immediately prior to each product
application in order to analyze long lasting or cumulative effects, while “acute samples” refer to
those collected to assess acute effects 15 minutes to 48 hours after the second weekly product
application. To determine the effects of lubricant use on inflammation, we analyzed cytokines
and other inflammatory markers from rectal secretions. Numerous cytokines peaked signifi-
cantly at acute time points post-lubrication [TNF-α (p = 0.024), IL-12 (p = 0.016), IL-15
(p = 0.015), G-CSF (p = 0.013), sCD40 (p = 0.050), IL-4 (p = 0.009), MCP-1 (p = 0.026), MIP-
1α (p = 0.014), and IL-1β (p = 0.008); Table 1]. Fig. 1, B and C show TNF-α induction as an ex-
ample for a pro-inflammatory cytokine upregulated at acute time points after lubricant use,
but not longitudinally during the six weeks of treatment. Rectal TNF-α peaked 30 minutes
after the second weekly lubricant application. Cytokines were not upregulated compared to
baseline in longitudinal samples collected over six weeks, suggesting no persistent or cumula-
tive effect of frequent lubricant use on these inflammatory markers.
Epithelial sloughing and blood
Tissue damage was examined by determining epithelial sloughing and associated blood in rec-
tal lavages. Fig. 2, A shows photographs of epithelial sheets with size>3mm in any dimension,
harvested from the rectum of a lubricant-treated macaque. The size of the sloughed cellular
material varied from 3mm to 20mm. Controls exhibited a lesser degree of epithelial shedding
(<3mm in any dimension), which is considered normal [18]. Histological examination showed
that the sloughed material was of cellular origin, consistent with the shedding of epithelium
(Fig. 2, A; lower panel). Blood associated with sloughed tissues was documented by visual and
microscopic examination of lavages (Fig. 2, B). Blood was only associated with epithelial sheets
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following lubricant application, and not in control animals. Fig. 2, C and D display the frequen-
cy of detected tissue fragments> 3mm in all evaluated macaques. Sloughing occurred in five of
six macaques 2 hours post-lubricant treatment, while only one of the three control macaques
had signs of this type of tissue sloughing at any acute time point. The difference in sloughing at
acute time points (Fig. 2, C) in the two study arms was not statistically significant (p = 0.1379;
2-tailed Fisher’s exact probability test). Fig. 2, D that displays all times points of collection (lon-
gitudinal) shows that sloughing did not increase over time. However maximum shedding of ep-
ithelium was seen in week 3 where all three collection points (over two days) showed sloughing
in up to 5 out of 6 lubricant-treated animals. At this point, sloughing was seen on day 1 (pre-lu-
bricant) and day 2 (post-lubricant) in only 1 out of 3 controls. The sloughing was also evident
in week 4 but in fewer macaques. S1 Fig. shows the time course of visually observed blood asso-
ciated with shed tissue fragments. Bleeding was first noted in some animals after week 1. Fol-
lowing repeated lubricant applications (weeks 4–6), blood in some lavage samples became
discernible by eye. It peaked at 4h post-application and was detected in 67% of lubricant ani-
mals, and in none of the controls.
Histology
Rectal biopsies were taken from one animal 30 min after the final lubricant application, and
they showed focal infiltrates of inflammatory cells (Fig. 3), predominantly mononuclear, seen
in the lamina propria; there was no disruption of architecture. Biopsies collected in one animal
a week after final lubricant application did not demonstrate significant tissue damage or in-
flammatory cell infiltration (H&E and IHC staining with CD3, CD6 or CD79) in lubricant-
treated macaques (data not shown)
Table 1. Cytokine concentration in rectal lavages at acute time points post lubricant/control buffer application.
Cytokine Conc1 (95% CI) for controls at acute time
points; pg/(mg of total proteins)
Conc1 (95% CI) for lubricant-treated animals at acute
time points; pg/(mg of total proteins)
p-value (control arm versus
lubricant-treated arm)
IL-1β 0.3638 (0.10,1.23) 3.2008 (1.76,5.79) 0.008
IL-4 1.016 (0.34,3.02) 5.813 (3.11,10.84) 0.009
G-CSF 0.0680 (0.004,1.11) 1.624 (0.43,6.09) 0.013
MIP-1α 1.443 (0.48,4.26) 3.688 (1.76,7.70) 0.014
IL-15 1.5786 (0.82,3.03) 3.1443 (2.04,4.85) 0.015
IL-12 0.8424 (0.28,2.49) 3.2886 (1.60,6.72) 0.016
TNF-α 0.091 (0.006,1.30) 3.245 (0.86,12.23) 0.024
MCP-1 1.948 (0.72,5.25) 11.364 (5.97,21.6) 0.026
sCD40 0.669 (0.13,3.75) 2.534 (0.80,8.00) 0.050
IFN-γ 0.090 (0.004,1.66) 0.611 (0.12,2.96) 0.093
TGFα 8.592 (4.62,15.97) 13.303 (8.62,20.53) 0.137
IL-8 11.303 (4.20,30.40) 63.247 (31.83,125.6) 0.179
IL-1Ra 27.769 (16.94,45.50) 86.328 (60.88,122.4) 0.199
VEGF 18.722 (7.51,46.64) 32.394 (17.48,60.01) 0.421
IL-18 26.935 (17.42,41.65) 25.907 (19.05,35.23) 0.732
The p-values were calculated using unpaired t-tests (see Materials & Methods for details); the statistically significant ones are indicated in bold;
CI = confidence interval.
1We calculated the geometric means (GMs) of cytokines concentrations as shown, combining the measurements at 15m, 30m, 2- and 4-h acute time
points. Levels of eight other cytokines were determined (see Methods) but many of the data points were below the assay limit of detection, and not
suitable for accurate statistical analyses
doi:10.1371/journal.pone.0120021.t001
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Fig 2. Epithelial sloughing and blood. A. Lubricant induces rectal shedding of epithelial cells. Examples of
epithelial sloughing in a control- (top left) and lubricant-treated animal (top right). The lower panel shows a
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Rectal microflora and pH
Lubricant application did not lead to a significant reduction in average levels of bacteria har-
vested from rectal swabs, analyzed in a subset of 5 animals (S2 Fig.) showing that the lubricant
did not directly reduce rectal microflora. The type and composition of the microflora (n = 5) var-
ied largely over time in both lubricant-treated and untreated macaques (data not shown). Due to
a limited data set, statistical analyses were not performed on differences in microflora type/com-
position. The median rectal pH was 7.9 (S3 Fig.), both before and after lubricant treatment
(p = 0.4230; unpaired 2-tailed Mann-Whitney test), despite the study lubricant’s pH of 4.4.
SHIV challenges and infections
In order to determine whether the observed, lubricant-induced cytotoxicity may affect HIV
risk, we used the cynomolgus macaque model to study rectal SHIVSF162P3 infection risk. Fig. 4
shows the study design; the lubricant was applied non-traumatically over three weeks, on two
consecutive days per week, and virus challenges occurred 30 minutes after the sixth lubricant
application since the cytokine levels peaked at 30 min post-application. We determined relative
susceptibility to infection by comparing the SHIVSF162P3 doses (AID50) needed for infection in
lubricant- or control buffer-treated macaques in two study arms. Macaques were first exposed
to low doses of virus, and if they remained uninfected, they were rested, and then re-enrolled at
higher doses until infection occurred. The virus exposure schedule for individual macaques can
be seen in S1 Table. In total, 21 macaques were challenged with various doses until 15 infec-
tions occurred in a total of 51 exposures (controls = 7, lubricant = 8). Table 2 summarizes the
number of virus exposures and outcomes. Unexpectedly, only two out of nine lubricant-treated
animals were infected at doses>2,500 TCID50. In contrast, six of the seven macaques were in-
fected in the control arm at those higher doses. In this study, we also used data from historical
controls, i.e., from 11 macaques exposed to SHIVSF162P3 at 50 or 250 TCID50s, with one infec-
tion occurring at each dose.
Risk of SHIV transmission
In order to define SHIV susceptibility to infection we used logistic regression models to esti-
mate the AID50. Contrary to the hypothesis that the lubricant may increase susceptibility to in-
fection, lubricant-treated macaques did not uniformly become infected at lower virus doses.
The estimated AID50 was 1.96x10
5 in the lubricant-treated arm and 1.7x103 in the controls (S4
Fig.). The 95% confidence interval (CI) for AID50 was 1.0–4.5x10
10 in lubricant-treated ma-
caques and 414–7165 in controls. The AID50 in the lubricant arm was not as well-defined as
the control arm because of a lack of as many infections at SHIV doses>2,500 TCID50. The esti-
mated AID50 ratio of lubricant-treated macaques to controls was 114 (95% CI: 4.0x10
−3–3.5 x
106), which was not statistically significantly different (p = 0.4467).
Plasma viremia and rectal virus shedding
After infection, and as shown in the study design (Fig. 4), we continued to apply lubricant for
at least 2 weeks to determine any effects on the course of SHIV infection and on genital
representative H&E stain of sloughed rectal epithelial cells (20x); B. Blood associated with rectal washes;
photographs of microfuges containing rectal lavages; C,D. Epithelial sloughing measured at acute time points
collected after the 2nd weekly lubricant application (C), and those measured over the entire study (D). The
panel D in this figure shows three collections per week (day 1, pre-lubricant; day 2 pre-lubricant; day 2 post-
lubricant), as indicated in Fig. 1.
doi:10.1371/journal.pone.0120021.g002
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shedding of virus. Fig. 5 displays the course of SHIVSF162P3 infection over time. The median
peak plasma viremia was 3.5 x107 viral copies/mL in the control arm and 1x106 viral copies/
mL in the lubricant arm, and was not significantly different (p = 0.1206; unpaired, two-tailed
Mann-Whitney test). Additionally, viral RNA levels in the two arms were compared at a
subsequent time point post-virus challenge when data points from all animals were available
(5 weeks). Again, we found the viral RNA levels did not differ significantly (p = 0.9551; un-
paired, two-tailed Mann-Whitney test). Virus shedding in rectal secretions is shown in Fig. 5,
B at the time of peak plasma viremia and during the ensuing two weeks during continued rectal
lubricant application. No statistically significant differences in rectal virus shedding were ob-
served (two-tailed Mann-Whitney test) at these time points.
Discussion
The evaluation of one highly osmolar lubricant revealed acute rectal cytotoxicity in cynomol-
gus macaques, as also observed by others in humans, mice, and in vitro systems [9–13]. When
we tested the hypothesis using a model of varying virus doses that lubricant-induced cytotoxic-
ity would increase rectal SHIV infection risk, we did not see evidence of heightened susceptibil-
ity to infection. The most likely explanation is that extent, type, and duration of cytotoxicity
and inflammation were not sufficient for detectable risk increases in this model. In particular,
inflammation and cytokine induction were largely short-lived (peaking at 30 minutes, and sub-
siding within two hours after lubricant use), and less pronounced than we have previously ob-
served during rectal co-infection with Chlamydia trachomatis in a similar macaque model [24].
Other cytotoxicity parameters such as bleeding and tissue sloughing were documented after lu-
bricant use, but were not significantly upregulated compared to buffer-treated macaques.
Despite the low pH of the test product, there were no significant changes in the pH of the
anal-rectal compartment perhaps reflecting the weak buffering capacity of the lubricant. The
limited data set on microflora showed no effects of lubricant application on microbial numbers.
Rectal biopsies taken in one animal 30 minutes post-product application showed mild inflam-
mation, whereas those taken 1 week after application did not show any inflammation. These
Fig 3. Hematoxylin and eosin stain (20x) of rectal biopsies. Showing biopsies from one animal (ID:
604962) collected before lubricant application (A) and 30 minutes after (B) product application; B shows focal
infiltrates of inflammatory cells (square box), predominately mononuclear, seen in the lamina propria; there is
no disruption of architecture. C is a magnified section (30x) of the square box with the green arrows showing
mononuclear cells.
doi:10.1371/journal.pone.0120021.g003
Fig 4. Challenge study design (Phase II). Lubricant was applied non-traumatically for three weeks, on two consecutive days per week. The animal was
challenged with SHIVSF162p3 30 minutes after the sixth lubricant application (open triangle). To check for plasma viremia and virus shedding, samples were
collected for at least 2 weeks post-peak viremia. Not shown are baseline blood draws that were performed before the first lubricant application to ensure that
the animal is not infected.
doi:10.1371/journal.pone.0120021.g004
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findings may be best explained by the ability of the rectum to rapidly repair itself after lubri-
cant-induced damage is inflicted, and cytotoxicity may not rise to a level that measurably af-
fects SHIV transmission. Recently, Dezzutti et al. tested a lubricant from the same product
family using ex vivo explants for its ability to enhance HIV-1 uptake and did not find evidence
for enhanced infection [9]. Future studies with rectal biopsies could involve more in-depth
analyses of immune infiltrates including study of cellular activation or death post-lubricant
application.
The overall lack of risk enhancement is perhaps not surprising in the context of nonoxynol-
9 (N9), a surfactant that has been studied for HIV risk impact [9]. N9 causes acute cytotoxicity
when rectally applied to macaques [25] but shows no long-lasting effects, similar to our study
findings. In humans, the impact of N9 might be dependent on frequency of use (shown in only
one study by Van Damme et al. [26]) but such correlations could not be determined in our
study because we did not model high frequency use.
It is possible that a different study design for lubricant application (e.g., timing and duration
of lubricant application and sampling, frequency, and trauma during use of the product) and
for risk assessment may have yielded different results. Repeated lubricant applications were
modeled after hypothesized human use on two weekend days. Limiting lubricant applications
to two days/week was also necessary to limit repeated anesthesia applications per week over
several weeks due to the necessary fasting, and associated weight loss in macaques. This al-
lowed us to give two lubricant applications, and use the third anesthesia for sample collections.
A higher lubricant application frequency might have increased the measurable damage, al-
though there was no evidence of lasting damage on the second day of the weekly applications.
It is possible that cytotoxicity peaked later than 30 minutes after lubricant applications but be-
fore our next time points. We chose the 30 minute time point for SHIV application because cy-
tokine induction was maximal at the time point, and also because a 30 minute interval between
lubricant application and intercourse with virus exposure was deemed a relevant scenario for
human lubricant use. Also, we used non-traumatic product application (without use of semen)
to achieve humane animal experimentation, but it does not entirely represent human lubricant
Table 2. SHIV162p3 challenge doses and infection.











‘+’ = animal infected at the indicated dose;
‘0’ = animal not infected;
PBS = phosphate buffered saline; TCID50 = tissue culture 50% infectious dose. The challenges were
performed in six sets of macaques; sets1 and 2 were phosphate buffered saline (PBS)-treated controls;
sets 3, 4, 5 and 6 were lubricant-treated.
1Historical data from 5 uninfected and 1 infected animals were included at 250 TCID50, and 4 uninfected
and 1 infected animals at 50 TCID50; these animals were non-PBS-treated
doi:10.1371/journal.pone.0120021.t002
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use during sex. It is possible that lubricant effects combined with mechanical trauma or semen
during sex would affect cytotoxicity and HIV risk more so than detected here. Taken together,
our study design and results may underestimate the effect of lubricant on cytotoxicity and also
SHIV risk. However, it is also possible that we underestimated protective effects of lubricants
in this model. Personal lubricants can protect from mechanical tissue damage during sex. Sex
was not modeled in this animal model, and protective properties could not be assessed. They
may outweigh the cytotoxic effects observed in this study.
Fig 5. Plasma and rectal SHIV RNA. A. Plasma SHIV RNA levels measured in control buffer-treated (black
symbols; solid lines) and lubricant-treated (grey symbols; broken lines) animals. B. SHIV RNA levels
measured in rectal secretions, in control buffer-treated (open symbols) and lubricant-treated (closed symbols)
animals; 0 = time of peak plasma viremia.
doi:10.1371/journal.pone.0120021.g005
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One unexpected finding was a seemingly wider range of susceptibilities to infection in lubri-
cant- compared to buffer-treated macaques. We used a model of varying virus doses similar to
Chenine et al [20] who reported a 17-fold difference in virus doses needed to infect Schistosoma
mansoni-infected macaques compared to S.mansoni-negative animals. Hence, the model can
provide great sensitivity in detecting enhanced risk. We started by establishing a virus dose in-
fection curve in control macaques, and exposed uninfected macaques to higher doses. Unex-
pectedly, several macaques remained uninfected at the highest doses (undiluted stocks), and
those resistant macaques were subsequently placed in the lubricant-treated group, which is a
limitation of the study. To address this, we added naive macaques to the lubricant group, and
they also remained uninfected at undiluted stock doses (e.g., animal ID = 70782; S1 Table). To
increase statistical power, non-PBS-treated cynomolgus macaques were included as historical
controls. Other limitations are that we cannot reproducibly test in non-human primates the
impact of lubricant on cell-to-cell transmission, and that the cynomolgus macaque model of
HIV susceptibility and transmission is not as well defined as rhesus or pigtail macaque models.
Also, we cannot confirm whether cytotoxicity was evident in macaques at the time of virus
challenges.
Several recent scientific studies have supported the hypothesis that hyper-osmolality of per-
sonal lubricants may be the leading cause of cytotoxicity [9,10,12]. Since we evaluated only a sin-
gle product, we cannot conclude whether hyper-osmolality or other physical and chemical
properties caused cytotoxicity. Subsequent to our selection of study lubricant theWHO issued an
advisory note to avoid procurement of lubricant products with osmolality>1,200 mOsm/kg,
with pH< 5.5, and containing PQ15 [17], which were properties that our study lubricant pos-
sessed [9,10]. More systematic evaluations, perhaps in species other than macaques with better
high-throughput capacity, are needed to determine the chemical basis for cytotoxicity.
In summary, this study constitutes a first step in the in vivo evaluation of lubricants with re-
gards to HIV transmission. A highly osmolar lubricant did not increase SHIV transmission
risk in cynomolgus macaques. This was reassuring considering the widespread use of products
with these properties. However our study had limitations, and we do not consider this study as
a sufficient scientific basis to draw definitive conclusions or to make recommendations on lu-
bricant use and HIV prevention. In the interim, correct and consistent use of condoms is rec-
ommended to prevent exposure to pathogens, including HIV, which the CDC and WHO




S1 Fig. Blood associated with rectal washes. The percentage of macaques with visible blood in
their rectal washes is plotted for time points acutely after product application (A), or for all
time points of specimen collection (B).
(TIF)
S2 Fig. Levels of harvested bacteria from rectal swabs.We found no significant difference
(unpaired, two-tailed t-test) between the two arms; bacteria were cultured and counted from
rectal swabs. “B” refers to baseline; three independent time points were analyzed. “+” refers to
product-treated, six time points were analyzed. Data was combined from two controls, and
three lubricant-treated animals. Lines are medians; open circles are from controls, filled circles
from the lubricant group.
(TIF)
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S3 Fig. Analysis of rectal pH. Application of a lubricant with pH of 4.4 does not significantly
alter rectal pH. Rectal fluids were collected with a cotton swab, and immediately applied to pH
strips. “B” baseline (Six independent time points); only “acute” time points (after second week-
ly product application) are shown; “m”minutes, “h” hours. Mean and SEM are shown; the
schematic refers to study design shown in Fig. 1.
(TIF)
S4 Fig. Probability of SHIV infection using a logistic regression models (including data
from historical controls). The estimated AID50 ratio (114) between the study arms did not
show statistically significant difference (p = 0.45); shown here are the dose curves for the con-
trol buffer-treated (black line) and lubricant-exposed (grey line) animals; the log10 value for
the lubricant arm was extrapolated.
(TIF)
S1 Table. SHIV challenge design showing the animal IDs. Sets1 and 2 were phosphate buff-
ered saline (PBS)-treated controls (c); sets 3, 4, 5 and 6 were lubricant-treated (L); ‘+’ = animal
infected; ‘−’ = animal not infected; historical controls are not shown here. The virus doses (in
TCID50) are indicated in parenthesis next to every SHIV challenge. During the cytotoxicity
testing phase of the study, animals 610214, 610268, and 607780 were PBS-treated, and animals
CY9813, 609290, 609354, 603306, 609320, and 604962 were lubricant-treated.
(PDF)
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